{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"41"}],"units":"Participants"}],"description":"Number of participants who required a doctor visit/emergency department visit and/or hospital admission due to persistent hypercalcemia and/or associated symptoms after the parathyroidectomy procedure will be categorized as binary (yes or no) if any follow-up visits or admissions occurred.","groups":[{"description":"For participants assigned to the study arm, the surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the parathyroid surgery.","id":"OG000","title":"Parathyroid Eye (PTeye)"},{"description":"The surgeon will proceed with the parathyroid surgery as usual, while relying solely on her/his surgical experience in identifying the parathyroid glands during the operations.","id":"OG001","title":"Usual Standard of Care"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 6 months after PTx procedure","title":"Number of Participants With Reported Doctor Visits/Emergency Department Visits or Hospital Admissions","type":"SECONDARY","unitOfMeasure":"participants"}